KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 107 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $956,166 | +233681.4% | 55,047 | +89.5% | 0.06% | +154.2% |
| Q2 2023 | $409 | -44.8% | 29,045 | -57.8% | 0.02% | -46.7% |
| Q1 2023 | $741 | -37.7% | 68,881 | -13.3% | 0.04% | -38.4% |
| Q4 2022 | $1,190 | -99.9% | 79,419 | +14.5% | 0.07% | +23.7% |
| Q3 2022 | $891,000 | +30.6% | 69,378 | -1.4% | 0.06% | +40.5% |
| Q2 2022 | $682,000 | -3.9% | 70,339 | -1.5% | 0.04% | +10.5% |
| Q1 2022 | $710,000 | -13.7% | 71,384 | +2.1% | 0.04% | -5.0% |
| Q4 2021 | $823,000 | +10.2% | 69,927 | +6.7% | 0.04% | +2.6% |
| Q3 2021 | $747,000 | +24.3% | 65,559 | +52.1% | 0.04% | +21.9% |
| Q2 2021 | $601,000 | – | 43,116 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,025,000 | $12,064,000 | 2.56% |
| GREAT POINT PARTNERS LLC | 536,738 | $6,317,000 | 1.40% |
| Endurant Capital Management LP | 244,125 | $2,873,000 | 0.69% |
| HHLR ADVISORS, LTD. | 2,920,023 | $34,369,000 | 0.53% |
| Integral Health Asset Management, LLC | 140,000 | $1,648,000 | 0.46% |
| Spearhead Capital Advisors, LLC | 235,024 | $2,766,000 | 0.33% |
| Jackson Creek Investment Advisors LLC | 77,069 | $907,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 712,807 | $8,390,000 | 0.30% |
| Parkman Healthcare Partners LLC | 113,644 | $1,338,000 | 0.30% |
| Birchview Capital, LP | 30,000 | $353,000 | 0.23% |